Universe Pharmaceuticals Inc (UPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-1990 | 12-1989 | 12-1988 | 12-1987 | 12-1986 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,710 | -22,269 | 25,611 | 10,074 | 13,384 |
| Depreciation Amortization | 8,642 | 8,016 | 6,761 | 6,427 | 5,671 |
| Other Working Capital | 78,949 | -19,264 | -60,192 | N/A | N/A |
| Other Operating Activity | 18,040 | 68,595 | 16,689 | 24,222 | 15,056 |
| Operating Cash Flow | $128,341 | $35,078 | $-11,131 | $40,723 | $34,111 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17,718 | -4,869 | N/A | 612 | 5,716 |
| Net Acquisitions | -4,723 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 271,935 | -144,183 | -378,534 | 214,195 | 277,149 |
| Investing Cash Flow | $249,494 | $-149,052 | $-378,534 | $214,807 | $282,865 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -9,298 | -8,306 | -5,001 | 203,038 | 422,283 |
| Other Financing Activity | -303,949 | 168,566 | 376,296 | 257,501 | -393,893 |
| Financing Cash Flow | $-313,247 | $160,260 | $371,295 | $460,539 | $28,390 |
| Beginning Cash Position | 292,975 | 246,689 | 233,469 | 252,574 | 495,836 |
| End Cash Position | 357,563 | 292,975 | 215,099 | N/A | N/A |
| Net Cash Flow | $64,588 | $46,286 | $-18,370 | $40,761 | $345,366 |
| Free Cash Flow | |||||
| Operating Cash Flow | 128,341 | 35,078 | -11,131 | 40,723 | 34,111 |
| Free Cash Flow | 128,341 | 35,078 | -11,131 | 40,723 | 34,111 |